Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
| ▸ | CDC14B | O60729 | 1/20 | 0.36 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 3/20 | 0.35 |
| ▸ | AHR | P35869 | 2/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | TTR | P02766 | 2/20 | 0.34 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30761751 | 0.85 | TTR (0.37) | LOXL2CDC14BCDC14AMAOAAHR | |
| SCHEMBL20033067 | 0.85 | TTR (0.37) | LOXL2CDC14BCDC14AMAOAAHR | |
| SCHEMBL23614316 | 0.84 | MAOA (0.39) | MAOAAHREGFRTTRKDM5A | |
| SCHEMBL19502218 | 0.84 | LOXL2 (0.41) | LOXL2CDC14BCDC14AMAOAAHR | |
| SCHEMBL29805226 | 0.84 | LOXL2 (0.41) | LOXL2CDC14BCDC14AMAOAAHR | |
| SCHEMBL18820546 | 0.79 | LOXL2 (0.40) | LOXL2AHRPARP1 | |
| SCHEMBL29709172 | 0.79 | LOXL2 (0.40) | LOXL2AHRPARP1 | |
| SCHEMBL23406935 | 0.78 | CDC14B (0.46) | LOXL2CDC14BCDC14AMAOAAHR | |
| SCHEMBL20739843 | 0.78 | MCL1 (0.41) | MAOAAHREGFRTTR | |
| SCHEMBL25056598 | 0.78 | MAOA (0.54) | LOXL2CDC14BCDC14AMAOAEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11683982-B2 | Organic compound having excellent thermal resistance property and luminescent property, organic light emitting diode and organic light emitting device having the compound | LG DISPLAY CO., LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-11683982-B2 | Organic compound having excellent thermal resistance property and luminescent property, organic light emitting diode and organic light emitting device having the compound | LG DISPLAY CO., LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-20200194685-A1 | ORGANIC COMPOUND HAVING EXCELLENT THERMAL RESISTANCE PROPERTY AND LUMINESCENT PROPERTY, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | LG DISPLAY CO., LTD. (KR) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11683982-B2 | Organic compound having excellent thermal resistance property and luminescent property, organic light emitting diode and organic light emitting device having the compound | DDT, DBF4, L3MBTL4 | LOXL2 1233/4885CDC14B 1718/4885CDC14A 1282/4885 |
| US-20200194685-A1 | ORGANIC COMPOUND HAVING EXCELLENT THERMAL RESISTANCE PROPERTY AND LUMINESCENT PROPERTY, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | DDT, DBF4, L3MBTL4 | LOXL2 1233/4885CDC14B 1718/4885CDC14A 1282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.